Posted on 23 November 2015
Tags: Allergan, big pharma, merger, Pfizer
US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. Read the full story
Posted on 18 November 2014
Tags: acquisition, Actavis, Allergan, big pharma, M&A
Actavis and Allergan have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock Read the full story
Posted on 19 August 2014
Tags: Allergan, m& A, Valeant
Valeant Pharmaceuticals has extended the acquisition period for Allergan. Read the full story
Posted on 15 August 2014
Tags: Allergan, pharma deal
Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program in a pharma deal. Read the full story
Posted on 03 June 2014
Tags: acquisition, Allergan, Valeant
Valeant Pharmaceuticals and Pershing Square plan to approach the shareholders of Allergan for a hostile takeover. Read the full story
Posted on 01 June 2014
Tags: Abbott, Actavis, Alcon, Allergan, Amgen, Apotex, Astellas, AstraZeneca, Baxter, Bayer, big pharma, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cephalon, Chugai, CSL, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, Forest, Genzyme, Gilead, Gilead Sciences, GlaxoSmithKline, Hospira, J&J, Kyowa Hakko Kirin, Lundbeck, Menarini, Merck, Merck KGaA, Mitsubishi, Mitsubishi Tanabe, Mylan, Novartis, Novo Nordisk, Nycomed, Otsuka, Pfizer, Roche, Sanofi, Servier, Shionogi, shire, Stada, Takeda, Teva, UCB, Warner Chilcott, Watson
The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story
Posted on 31 May 2014
Tags: Allergan, big pharma
Allergan is a top pharmaceutical company based in Irvine, California,USA Read the full story
Posted on 13 May 2014
Tags: acquisition, Allergan, M&A, Valeant
Allergan announced that its Board of Directors has unanimously rejected the unsolicited proposal announced by Valeant Pharmaceuticals International, Inc. on April 22, 2014. Read the full story
Posted on 07 May 2014
Tags: acquisition, Allergan, M&A, Valeant
Allergan is currently the subject of much speculation as Valeant Pharmaceuticals looks to acquire it. Valeant Pharmaceuticals, well known for building its company via acquisitions, put in a $46 billion bid one week ago to acquire Californian based botox maker Allergan. Read the full story
Posted on 30 April 2014
Tags: Allergan, big pharma, dealtalk
Allergan has contacted companies including Sanofi and Johnson & Johnson to see if either would be interested in acquiring the Botox maker, said people with knowledge of the matter, as it explores its options after receiving an unsolicited $45.7 billion bid from Valeant Pharmaceuticals International Inc. Read the full story